Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	2.3800668102827445e-05	100.81761006289308	-216.95395722754864	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	2.3800668102827445e-05	116.26086956521739	-240.55570695978312	IL6;TLR4;TNF;VCAM1
KEGG_2021_Human	Inflammatory bowel disease	4/65	7.733227471018954e-07	2.706629614856634e-05	87.50819672131148	-195.3419859289311	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	3.8215390226519425e-05	74.03703703703704	-172.05130589538587	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	4/100	4.3860489555289296e-06	5.3874206899469535e-05	55.361111111111114	-136.84140632930726	IL6;NFKB1;TNF;VCAM1
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	5.3874206899469535e-05	53.12	-132.3420645012429	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	5.3874206899469535e-05	54.21768707482993	-134.5540755438832	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	5.130876847568527e-06	5.3874206899469535e-05	53.12	-132.3420645012429	NFKB1;TLR4;TNF;VCAM1
KEGG_2021_Human	Lipid and atherosclerosis	5/215	2.882246411730869e-06	5.3874206899469535e-05	37.41904761904762	-118.71127334987257	IL6;NFKB1;TLR4;TNF;VCAM1
KEGG_2021_Human	Amoebiasis	4/102	4.7476288106462685e-06	5.3874206899469535e-05	54.21768707482993	-134.5540755438832	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	TNF signaling pathway	4/112	6.897261761044327e-06	6.583749862815039e-05	49.135802469135804	-124.17448810278691	IL6;NFKB1;TNF;VCAM1
KEGG_2021_Human	African trypanosomiasis	3/37	1.0384632752750053e-05	9.086553658656298e-05	101.26890756302521	-158.85054794063166	IL6;TNF;VCAM1
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.0001240917327932044	39.774436090225564	-104.03256013781805	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	4/155	2.5031430482156457e-05	0.00018773572861617344	34.95364238410596	-93.05983781717019	ADIPOQ;IL6;NFKB1;TNF
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.00020855684882803421	33.37552742616034	-89.36652156273904	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.0002475039644453487	31.349206349206348	-84.54495262531024	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.0002688051794432243	29.721280602636536	-80.60331713278154	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Tuberculosis	4/180	4.508970382755845e-05	0.0002688051794432243	29.893939393939394	-81.02434645013932	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.000354893980590721	27.202072538860104	-74.37625984844887	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Adipocytokine signaling pathway	3/69	6.857856994284154e-05	0.00036003749219991815	51.96103896103896	-96.07609532933417	ADIPOQ;NFKB1;TNF
KEGG_2021_Human	Leishmaniasis	3/77	9.524734696085732e-05	0.0004762367348042866	46.2972972972973	-87.57744084010389	NFKB1;TLR4;TNF
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.0005798890881431943	22.923976608187136	-63.412309433922275	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.0007249561787478016	21.287074829931974	-59.07439560833883	IL6;NFKB1;TLR4;TNF
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0007249561787478016	37.56828885400314	-73.71479219141467	IL6;NFKB1;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0007249561787478016	37.99047619047619	-74.4091590745228	IL6;TLR4;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0009408298511400269	33.806223479490804	-67.40758155759835	IL6;NFKB1;TNF
KEGG_2021_Human	Insulin resistance	3/108	0.00026049631963660937	0.0010038513362638387	32.50204081632653	-65.16806085544759	IL6;NFKB1;TNF
KEGG_2021_Human	HIF-1 signaling pathway	3/109	0.00026769368967035696	0.0010038513362638387	32.19137466307278	-64.6303441766756	IL6;NFKB1;TLR4
KEGG_2021_Human	Toxoplasmosis	3/112	0.00029005838446074546	0.0010502113920130439	31.293577981651374	-63.06696788213405	NFKB1;TLR4;TNF
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.0018548817966230408	24.99579831932773	-51.672386684351224	IL6;NFKB1;TLR4
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.0018548817966230408	24.99579831932773	-51.672386684351224	NFKB1;TNF;VCAM1
KEGG_2021_Human	Alzheimer disease	4/369	0.0007223109472324288	0.0023700827956064066	14.069406392694065	-38.837531411044004	APOE;IL6;NFKB1;TNF
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.0036803480230820766	50.175	-57.95352918467438	IL6;TNF
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.0042826546165521204	45.59090909090909	-53.767249912981214	ADIPOQ;TNF
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0016236545858167558	0.004870963757450267	16.946877243359655	-35.79178563433967	IL6;NFKB1;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.005442326218207948	16.115516062884485	-34.04865723073064	NFKB1;TLR4;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.005813101809402028	15.579365079365079	-32.91284230349772	IL6;NFKB1;TNF
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.006116262361075788	15.146718146718147	-31.989452913184095	IL6;NFKB1;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.006966418379908695	32.8155737704918	-41.182346051003734	IL6;NFKB1
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.007498225492394042	13.800705467372135	-29.076248648200146	NFKB1;TLR4;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.008156347116520635	29.41176470588235	-37.553176952571945	NFKB1;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.012727832266142306	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.012727832266142306	22.933908045977013	-30.23706529396038	NFKB1;TLR4
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.013539417878165148	21.67391304347826	-28.742216935482162	HAMP;TNF
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.014608189404280209	20.54381443298969	-27.37901341152302	IL6;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.014608189404280209	20.331632653061224	-27.120602948412195	IL6;TNF
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.014858275933632857	19.92	-26.61700675496218	ADIPOQ;NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.015107748749113735	19.524509803921568	-26.130280011490946	NFKB1;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.01563876729185655	18.95952380952381	-25.42995427691617	IL6;NFKB1
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.016706322078142398	9.422466422466423	-19.140881053489387	IL6;NFKB1;TLR4
KEGG_2021_Human	Sphingolipid signaling pathway	2/119	0.008964014539605185	0.01845532405212832	16.98931623931624	-22.939511285821055	NFKB1;TNF
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.02051805871910422	15.886	-21.510038502238015	NFKB1;TNF
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.024939556979720362	14.157142857142857	-19.21549786230027	NFKB1;TNF
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.02910784952424966	12.847402597402597	-17.429441058365175	IL6;NFKB1
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.02910784952424966	12.762903225806452	-17.312716751580805	NFKB1;TNF
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.0292846635047637	12.597133757961783	-17.083187709957596	TLR4;TNF
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.032738201127885225	6.897094430992736	-13.07371705691191	IL6;NFKB1;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.036523436327028404	6.556709956709956	-12.239051897711217	IL6;NFKB1;TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.03854103669845057	10.536096256684491	-14.167050995225416	NFKB1;TLR4
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.03877352205325272	10.365789473684211	-13.920708621090329	IL6;NFKB1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.03877352205325272	10.31020942408377	-13.840129933766221	IL6;NFKB1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.042712123976084995	9.685960591133005	-12.928804077098514	TLR4;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.06290086989951545	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.0702377646484455	7.192804428044281	-9.169844698845731	IL6;TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.07444188620370985	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.07723094168374264	6.657534246575342	-8.337786615237395	NFKB1;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.07723094168374264	6.6339590443686	-8.300944532041967	IL6;TNF
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.0802973940545455	21.232804232804234	-12.171283962486152	TNF
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.08200816823099433	6.298701298701299	-7.775300015246377	MIR483;NFKB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.08683214381728678	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.08717059199235631	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Cholesterol metabolism	1/50	0.060233261208856796	0.08717059199235631	18.183673469387756	-10.63265628196324	APOE
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.08717059199235631	5.880699088145897	-7.115618067766183	NFKB1;TNF
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.11345113621314795	13.47138047138047	-8.082458738692866	NFKB1
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11354632051306683	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.11372399491206925	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.11372399491206925	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	PPAR signaling pathway	1/74	0.0879683156429337	0.11841888644241075	12.168949771689498	-7.333238410134627	ADIPOQ
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.1184478408236618	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.1184478408236618	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.11993140406831672	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.12282149589510287	11.094444444444445	-6.698191160265787	NFKB1
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.13535469692458676	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.13535469692458676	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.1390080123748795	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.1390080123748795	9.226851851851851	-5.553951626329874	NFKB1
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.15998639503097184	7.822025565388397	-4.655477238055189	VCAM1
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.16225640922667814	3.5628544423440456	-3.410136075895621	IL6;NFKB1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.16225640922667814	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.16225640922667814	7.4220354808590105	-4.393179099544486	ADIPOQ
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.17038225001766738	6.7846153846153845	-3.968927686510734	TNF
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.17038225001766738	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.17038225001766738	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Systemic lupus erythematosus	1/135	0.15517650047822218	0.17333545266184391	6.5787728026534	-3.830244937455702	TNF
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.18668970417487757	5.987150415721844	-3.427000500776257	VCAM1
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.18932236320957327	5.82560706401766	-3.3156870475343334	TLR4
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.18962795538305233	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.19657969161236552	5.456866804692892	-3.0596637281364782	IL6
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.226878047958299	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.23371974892374006	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.23371974892374006	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.24451143273139128	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.25782081765227016	3.7696007696007694	-1.8563524399324505	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.2620480858348149	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
